Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.44
Delayed Data
As of 4:00pm ET
 +0.27 / +6.47%
Today’s Change
3.90
Today|||52-Week Range
7.88
-17.01%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close4.17
Today’s open4.15
Day’s range4.15 - 4.48
Volume51,524
Average volume (3 months)1,439,997
Market cap$596.2M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+59.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.05+0.61%
HRTXHeron Therapeutics I...+0.20+1.29%
BYSIBeyondspring Inc+2.41+8.47%
TGTXTG Therapeutics Inc+0.15+1.86%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Laurence James Neil Cooper
Executive VP, Chief Operating &
Business Officer
David M. Mauney
Corporate headquarters
Boston, Massachusetts

Forecasts